Percutaneous Needle Electrolysis Versus Surgery in the Treatment of Carpal Tunnel Syndrome

December 30, 2019 updated by: Jose Antonio Garcia Vidal, Universidad de Murcia
The aim of this study is to compare the effectiveness of Percutaneous Needle Electrolysis (PNE) versus surgical treatment in the treatment of Carpal Tunnel Syndrome (CTS).

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

140

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Over 18 years.
  • CTS diagnosed by Electromyography (EMG)
  • Symptoms of CTS + EMG

Exclusion Criteria:

  • Difficulty expressing your feelings properly
  • Unsurpassed fear of needles
  • History of adverse reactions to needles
  • Epilepsy and / or allergies to metals.
  • Difficulty expressing your feelings properly
  • Existence of diffuse peripheral neuropathy or cervical radiculopathy
  • History of potential concurrent cause of idiopathic CTS (such as diabetes, thyroid, chronic rheumatoid arthritis, renal failure with hemodialysis, pregnancy..)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: PNE group
Patients received 4 sessions, separated one week between them. The treatment consisted the application of a galvanic current through an acupuncture needle (0,30x30mm). The approach were performed with a transverse axis with a needle in plane, being superficial and deep interface of medium nerve the target tissue. The parameters will be 2 mA (milliamps), 10 seconds, 3 impacts (3: 3: 3).
Percutaneous Needle Electrolysis: the application of galvanic current through an acupuncture needle.
EXPERIMENTAL: Surgery group
Patients received surgery for median nerve release.
Median nerve release

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of the Boston Questionnaire for Carpal Tunnel Syndrome
Time Frame: Baseline and after treatments: 6 weeks, 3 months, 6 months and 12 months
11-question patient-administered survey that rates the severity of the patient's carpal tunnel syndrome-specific symptoms on a scale of 1 (no symptoms) to 5 (worst symptoms)
Baseline and after treatments: 6 weeks, 3 months, 6 months and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of the Clinical Symptoms Carpal Tunnel Syndrome Scale
Time Frame: Baseline and after treatments: 6 weeks, 3 months, 6 months and 12 months
Describe the symptoms of the hand and wrist (pointing to them in a drawing), and using scales of 1 to 5 (1= No difficulty to do it; 5= I can´t do it), measure the difficulty of performing certain activities (writing, buttoning, holding a book ...)
Baseline and after treatments: 6 weeks, 3 months, 6 months and 12 months
Change of pain level
Time Frame: Baseline and after treatments: 6 weeks, 3 months, 6 months and 12 months
Visual Analogue Scale (VAS: 0=no pain; 100= pain as bad as can be)
Baseline and after treatments: 6 weeks, 3 months, 6 months and 12 months
Change of Semmes Weinstein Mini monofilament kit
Time Frame: Baseline and after treatments: 6 weeks, 3 months, 6 months and 12 months
Contact threshold, to assess if there is a decrease in sensitivity
Baseline and after treatments: 6 weeks, 3 months, 6 months and 12 months
Change of the Hand Dynamometer
Time Frame: Baseline and after treatments: 6 weeks, 3 months, 6 months and 12 months
Hand grip force
Baseline and after treatments: 6 weeks, 3 months, 6 months and 12 months
Changes of the Muscles strength by Kendall´s scale
Time Frame: Baseline and after treatments: 6 weeks, 3 months, 6 months and 12 months
Muscular strength of Opponens pollicis and Abductors policies. Scale of 0 to 5 (0=No visible or palpable contraction; 5=Full ROM against gravity, maximum resistance)
Baseline and after treatments: 6 weeks, 3 months, 6 months and 12 months
Changes of the SF-12 Questionnaire (Short Form 12 Questionnaire)
Time Frame: Baseline and after treatments: 6 weeks, 3 months, 6 months and 12 months
12 questions self-administered. Assess quality of life, general health and well-being using scales of 1 to 5 (1= Ever; 5= Never)
Baseline and after treatments: 6 weeks, 3 months, 6 months and 12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Direct and indirect health cost measures
Time Frame: 12 months after treatments
Number of visits to the specialist, number of hospitalization days, number of physiotherapy sessions, prescribed medication, days of work absenteeism
12 months after treatments

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 1, 2015

Primary Completion (ACTUAL)

January 1, 2019

Study Completion (ACTUAL)

January 31, 2019

Study Registration Dates

First Submitted

December 28, 2019

First Submitted That Met QC Criteria

December 30, 2019

First Posted (ACTUAL)

January 2, 2020

Study Record Updates

Last Update Posted (ACTUAL)

January 2, 2020

Last Update Submitted That Met QC Criteria

December 30, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carpal Tunnel Syndrome

Clinical Trials on PNE

3
Subscribe